The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lemsip Cough and Cold Capsules with CaffeineParacetamol 500mgGuaifenesin 100mgCaffeine 25mg



Reckitt Benckiser Ireland LtdPA0979/029/001

Main Information

Trade NameLemsip Cough and Cold Capsules with CaffeineParacetamol 500mgGuaifenesin 100mgCaffeine 25mg
Active SubstancesParacetamol
Guaifenesin
Caffeine anhydrous
Dosage FormCapsule, hard
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/029/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics

Status

License statusAuthorised
Licence Issued22/06/2007
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicencePharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale. Promotion to the public: Pack size not more than 24.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back